NO20006381L - Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler - Google Patents

Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Info

Publication number
NO20006381L
NO20006381L NO20006381A NO20006381A NO20006381L NO 20006381 L NO20006381 L NO 20006381L NO 20006381 A NO20006381 A NO 20006381A NO 20006381 A NO20006381 A NO 20006381A NO 20006381 L NO20006381 L NO 20006381L
Authority
NO
Norway
Prior art keywords
compositions
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
NO20006381A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006381D0 (no
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006381L publication Critical patent/NO20006381L/no
Publication of NO20006381D0 publication Critical patent/NO20006381D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006381A 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler NO20006381D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006381L true NO20006381L (no) 2000-12-14
NO20006381D0 NO20006381D0 (no) 2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006381A NO20006381D0 (no) 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Country Status (29)

Country Link
EP (1) EP1085867A1 (ru)
JP (1) JP2002518328A (ru)
KR (1) KR20010052817A (ru)
CN (1) CN1305378A (ru)
AP (1) AP9901581A0 (ru)
AR (1) AR018868A1 (ru)
AU (1) AU3342099A (ru)
BG (1) BG105128A (ru)
BR (1) BR9911357A (ru)
CA (1) CA2335112A1 (ru)
CO (1) CO5070586A1 (ru)
EA (1) EA200001189A1 (ru)
GT (1) GT199900083A (ru)
HR (1) HRP20000857A2 (ru)
HU (1) HUP0102395A2 (ru)
ID (1) ID26726A (ru)
IL (1) IL139587A0 (ru)
IS (1) IS5727A (ru)
MA (1) MA26648A1 (ru)
NO (1) NO20006381D0 (ru)
OA (1) OA11569A (ru)
PA (1) PA8472101A1 (ru)
PE (1) PE20000633A1 (ru)
PL (1) PL345064A1 (ru)
SK (1) SK18902000A3 (ru)
TN (1) TNSN99118A1 (ru)
UY (1) UY25557A1 (ru)
WO (1) WO1999065488A1 (ru)
ZA (1) ZA993973B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
ES2319785T3 (es) * 2001-11-29 2009-05-12 Gtx, Inc. Prevencion y tratamiento de osteoporosis inducida por privacion de androgenos.
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EA200901077A1 (ru) 2007-02-09 2010-04-30 Транзим Фарма, Инк. Макроциклические модуляторы грелинового рецептора и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (ru) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)Цис-6(S)-фенил-5(R)-[4-(2-пирРолидин-1-илетокси)фенил]-5,6,7,8-тетрагидронафталин-2-ол D-тартрат, способ его получения, способы лечения заболеваний поддающихся лечению агонистами эстрогена, и фармацевтическая композиция
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
ID26726A (id) 2001-02-01
EP1085867A1 (en) 2001-03-28
IS5727A (is) 2000-11-24
WO1999065488A1 (en) 1999-12-23
PL345064A1 (en) 2001-11-19
TNSN99118A1 (fr) 2005-11-10
EA200001189A1 (ru) 2001-06-25
JP2002518328A (ja) 2002-06-25
PE20000633A1 (es) 2000-07-26
BG105128A (en) 2001-11-30
BR9911357A (pt) 2001-03-13
HUP0102395A2 (hu) 2001-11-28
KR20010052817A (ko) 2001-06-25
AP9901581A0 (en) 1999-06-30
IL139587A0 (en) 2002-02-10
HRP20000857A2 (en) 2001-10-31
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
MA26648A1 (fr) 2004-12-20
CA2335112A1 (en) 1999-12-23
AU3342099A (en) 2000-01-05
AR018868A1 (es) 2001-12-12
NO20006381D0 (no) 2000-12-14
ZA993973B (en) 2000-12-15
SK18902000A3 (sk) 2001-12-03
CO5070586A1 (es) 2001-08-28
GT199900083A (es) 2000-12-05

Similar Documents

Publication Publication Date Title
AU2001258138A1 (en) Bone plate for the fixation of fractures of the proximal humerus
SI1389963T1 (sl) Kostna ploscica za fiksiranje zlomov proksimalnega humerusa
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
AU651369B2 (en) Method and apparatus for the fixation of bone fractures, limb lengthening and the correction of deformities
EP1236475A3 (en) Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
NO20006381L (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
AP9801269A0 (en) Prostaglandin agonists.
BG105125A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
DK1420827T3 (da) 5-CNAC sp, oralt indgivelsesmiddel for parathyroidhormonfragmenter
NO20006312L (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
UA26204C2 (uk) Спосіб запобігаhhя деградації кісткового протеза
HUP0202396A2 (hu) Törések kezelésére alkalmas gyógyszerkészítmények
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
DK0966968T3 (da) Terapeutiske kombinationer, der omfatter en selektiv östrogenreceptormodulator og prostaglandin E2
WO2001032191A3 (en) Phytoestrogenic pharmaceutical preparations
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
TH57984A3 (th) การรวมในทางการรักษาซี่งประกอบด้วยตัวปรับตัวรับเอสโตรเจนแบบคัดเลือกและฮอร์โมนพาราไธรอยด์
AU2001265248A1 (en) Measurement of the therapeutic dose for bone marrow ablation therapy
RU2003125500A (ru) Способ лечения переломов проксимального отдела бедренной кости с отрывом малого вертела при коксартрозе
AU5262000A (en) Implantable device for lengthening and correcting malpositions of skeletal bones
UA28851A (ru) Способ оперативного лечения переломов дистального метаэпифиза большой берцовой кости

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application